Type: | Synthesis Material Intermediates |
---|---|
Appearance: | Powder |
Quality: | Refined |
Colour: | White |
Product Name: | Ribaviri N |
Other Name: | Aas Powder |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Introduction |
Ribaviri is an antiviral drug that is a synthetic nucleoside that inhibits many DNA and RNA viruses and its mechanism is unclear. The US Food and Drug Administration only permits the treatment of hepatitis C, human respiratory fusion virus, and certain haemorrhagic fever with long-acting therapy. Ribaviri was synthesized by Joseph T. Witkowski, an ICN pharmaceutical company in 1970. FDA clearly pointed out that ribaviri is not suitable for the treatment of influenza, and strict indications, and the abuse of ribaviri to treat a variety of viral infections in China is very common. |
Function |
1. Severe hospitalized patients with bronchiolitis and pneumonia caused by a respiratory syncytial virus (RSV) in infants and young children (aerosol); 2. For the treatment of Lassa fever or epidemic hemorrhagic fever (with renal syndrome) Patients with symptoms or pneumonia) (intravenous drip or oral); 3. For the treatment of chronic hepatitis C (combined with recombinant α2b or peg α); 4. Prevention and treatment of viral upper respiratory tract infections (nasal drops). |
Application |
Respiratory system drugs Chemical medicine Antiviral drugs Antiparasitic and antithyroid drugs.. |
Item
|
Value
|
Purity
|
99%
|
Appearance
|
White Fine Powder
|
Storage
|
Cool Dry Place
|
Package
|
1g/bag
|
MOQ
|
1g/box
|
Sample
|
Free sample
|
Shelf life
|
2 Years
|
Certificate
|
ISO 9001 COA MSDS
|
Payment term
|
Trade Assurance or any other you like
|
Delivery time
|
Within 1-2 Working Days Payment
|
Suppliers with verified business licenses